ExoDx -Prostate Test: At-Home Collection Kit
The ExoDx Prostate is a simple, non-invasive urine test that can discriminate the risk of aggressive prostate cancer (defined as Gleason Score ≥7). This test is now available as an At-Home Collection Kit that can be initiated by an electronic order signed by the physician and sent directly to the patient’s home for self-collection.
The ExoDx™ Prostate Test is a simple, non-DRE, urine-based, liquid biopsy test indicated for men 50 years of age and older with a prostate-specific antigen (PSA) 2-10ng/mL, or PSA in the “gray zone” who may be considering a biopsy. The ExoDx Prostate test provides a risk score that determines a patient’s potential risk of clinically significant prostate cancer (Gleason Score ≥7). The test is included in the National Comprehensive Cancer Network (NCCN) guidelines and has been clinically validated at the cut-point of 15.6 with a 91% sensitivity and 92% negative predictive value, meaning there is less than a 9% chance of having aggressive prostate cancer below the validated cut-point of 15.6.
- Patients collect a sample in the comfort and convenience of their home and FedEx will pick up the specimen from their home and overnight it directly to the ExosomeDx Laboratory. A result is provided to the ordering physician 3-5 days upon sample receipt.
- Telemedicine visit? The ExoDx Prostate test provides the patient and physician an additional tool in the shared biopsy decision.
- Minimize Patients in the Office/Optimize Office Capacity: When office space and patient appointment times are limited, the ExoDx Prostate At-Home Collection Kit provides an actionable result that helps inform both the physician and patient to determine the biopsy decision in a virtual environment.
- An ExoDx Prostate Test can improve confidence in the decision to proceed to or defer the prostate biopsy procedure